Abstract:Identifying novel therapeutic agents is a fundamental challenge in contemporary drug development, especially in the context of complex diseases like cancer, neurodegenerative disorders, and metabolic syndromes. Here, we present a comprehensive computational study to identify potential inhibitors of SIRT1 (Sirtuin 1), a critical protein involved in various cellular processes and disease pathways. Leveraging the concept of drug repurposing, we employed a multifaceted approach that integrates molecular docking and molecular dynamics (MD) simulations to predict the binding affinities and dynamic behavior of a diverse set of FDA-approved drugs from DrugBank against the SIRT1. Initially, compounds were shortlisted based on their binding affinities and interaction analyses to identify safe and promising binding partners for SIRT1. Among these candidates, Doxercalciferol and Timiperone emerged as potential candidates, displaying notable affinity, efficiency, and specificity towards the binding pocket of SIRT1. Extensive evaluation revealed that these identified compounds boast a range of favorable biological properties and prefer binding to the active site of SIRT1. To delve deeper into the interactions, all-atom MD simulations were conducted for 500 nanoseconds (ns). These simulations assessed the conformational dynamics, stability, and interaction mechanism of the SIRT1-Doxercalciferol and SIRT1-Timiperone complexes. The MD simulations illustrated that the SIRT1-Doxercalciferol and SIRT1-Timiperone complexes maintain stability over a 500 ns trajectory. These insightful outcomes propose that Doxercalciferol and Timiperone hold promise as viable scaffolds for developing potential SIRT1 inhibitors, with implications for tackling complex diseases such as cancer, neurodegenerative disorders, and metabolic syndromes.

New sirtuin modulators: their uncovering, pharmacophore, and implications in drug discovery

Research progress on Sirtuins (SIRTs) family modulators

Current Trends in Sirtuin Activator and Inhibitor Development

Activation and inhibition of sirtuins: From bench to bedside

Recent Advances in the Discovery of SIRT1/2 Inhibitors via Computational Methods: A Perspective

A pharmacological review on SIRT 1 and SIRT 2 proteins, activators, and inhibitors: Call for further research

Small Molecules as SIRT Modulators

The sirtuin family in health and disease

A review on SIRT3 and its natural small molecule activators as a potential Preventive and therapeutic target

SIRT1 Activation by Natural Phytochemicals: An Overview

Sirtuin insights: bridging the gap between cellular processes and therapeutic applications

Sirtuins as Players in the Signal Transduction of Citrus Flavonoids

Sirtuins and Their Biological Relevance in Aging and Age-Related Diseases.

SIRT3 Activation a Promise in Drug Development? New Insights into SIRT3 Biology and Its Implications on the Drug Discovery Process

Emerging roles of SIRT1 activator, SRT2104, in disease treatment

Unraveling the multifaceted role of SIRT7 and its therapeutic potential in human diseases

The (patho)physiological roles of the individual deacylase activities of a sirtuin

SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases

Molecular Docking‐based Virtual Screening and Dynamics Simulation Study of Novel and Potential SIRT7 Inhibitors

Targeting Sirtuin 1 for therapeutic potential: Drug repurposing approach integrating docking and molecular dynamics simulations

Mitochondrial Sirtuin 3: New emerging biological function and therapeutic target